Rus Eng
Main / Company's news / The vice-governor Igor Golikov visited the R&D Center of GEROPHARM

The vice-governor Igor Golikov visited the R&D Center of GEROPHARM

28 January 2013

January 24th, Vice-Governor of St. Petersburg, Igor Golikov visited the special economic zone "Saint-Petersburg", the "Neudorf" area. The delegation included also the Chairman of the Committee for Industrial Policy and Innovation, Maxim Meyksin, and Head of the Area Development and Projects Maintenance, Vladimir Smirnov.

A special tour of the R&D Center of the Company "Geropharm" (JSC "Farm Holding") was organized for the guests. During the tour they attended high-tech premises of the Research Center - laboratory for the substances synthesis, analytical laboratoy and laboratories for development of finished dosage forms.

The own R&D Center of the company was opened in December 2011 as part of a pharmaceutical cluster in the special economic zone "Neudorf". The Research center specializes in drug development on the full cycle principle: from the synthesis of molecules to the development of finished dosage form, it also organizes pre-clinical and clinical studies.

Areas of Research are neurology, ophthalmology, hepatology, urology, gynecology, endocrinology, serious cardiovascular disorders. The R&D Center fully satisfies internationally accepted standards of Good Laboratory Practice GLP (Good Laboratory Practice) and has the advanced equipment. In the near future the company is planning to increase the area of the R&D center by establishing new and expanding existing laboratories.

The particular interest of the vice-governor was drawn to the development degree of insulin and medicines participating in the federal target program "Development of the Pharmaceutical and Medical Industry of the Russian Federation for the Period up to 2020 and beyond". Director of the R&D Center, Oleg Granstrem, spoke about the production area of the company in Obolensk city. The new plant, which will be opened in 2013, will produce modern pharmaceuticals for the treatment of diabetes and other socially-significant diseases.

JSC "Geropharm-Bio" (formerly "National Biotechnology") is Russia's first commercial full-cycle producer of recombinant human insulin. Today the capacity of the company allows providing 20% of the country's need for insulin. A key aspect here is the strategically-independent production from foreign suppliers.

You are a health care professional?

Go up